Market Overview

CBD, Still A Restricted Substance

Share:
CBD, Still A Restricted Substance

On December 20th the 2019 Farm Bill was signed into law by President Trump, with overwhelming bipartisan support from both the House (386 to 47) and the Senate (87 to 3). This $867 billion bill will provide needed subsidies for American farmers, strengthens the food stamps (SNAP) program, and, most importantly for the cannabis industry, removes hemp from the Control Substances Act.

As many of you know, hemp and marijuana are both sub-species of the Cannabis sativa plant. Hemp, which has been bred for centuries to produce fiber for industrial purposes, is generally defined as having less than .03% THC, the chemical compound in this family of plants (referred to as cannabinoids) that has a psychoactive effect on users. Hemp is also rich in CBD, a cannabinoid thought to have significant medical and wellness benefits. Marijuana, on the other hand, has THC levels of between 15% to 40%.

It is questionable why hemp was ever deemed to be a controlled substance, and now that it has been eliminated from the Act, hemp production will be legal in 50 states for both industrial use and hemp-derived CBD. This will likely contribute significantly to the estimated ~ $2B overall CBD market in 2022.

Much has been written about CBD as an ingredient for food and drinks. You can buy CBD infused coffee at Kave in Bushwick Brooklyn, cocktails at Adriaen Block in Queens (try the Stoney Negroni!), and countless candies and snacks from national retailers like Walmart Inc (NYSE: WMT), Kroger Co (NYSE: KR), and CVS Health Corp(NYSE: CVS).

But with all this euphoria and impending freedom to consume, remember, CBD as a food and drug ingredient now falls under the FDA’s purview. The FDA has already come out strongly reminding people that cannabis, hemp, and cannabis/hemp-derived compounds will be subject to their regulation, the framework for which has yet to be put in place. From what I have read, CBD products will remain restricted until regulations are put in place.

From FDA Commissioner Dr. Scott Gottlieb:

“…it’s unlawful under the FD&C Act to introduce food containing added CBD or THC into interstate commerce, or to market CBD or THC products as, or in, dietary supplements, regardless of whether the substances are hemp-derived. This is because both CBD and THC are active ingredients in FDA-approved drugs and were the subject of substantial clinical investigations before they were marketed as foods or dietary supplements…”

This is a very important nuance in the market. I do not expect CBD products will be allowed to carry any claims, even those typically allowed for dietary supplements with the disclaimer “These claims have not been verified by the FDA…”, unless the FDA changes its current stance.

Posted-In: 2018 Farm Bill cannabis industry New Frontier DataCannabis Government News Markets

 

Related Articles (CVS + KR)

View Comments and Join the Discussion!

Cannabis Movers

Sign up for our secret cannabis newsletter!
Never miss out on the breaking news in the Cannabis Industry!

Teva Has Potential For 6% CAGR Ahead, UBS Says In Upgrade

Raymond James Stays Bullish On Halliburton, Lowers Estimates On Tough 2019 Forecast